The global Cancer Biologics Market is estimated to be valued at US$ 94.5 Bn in 2023 and is expected to exhibit a CAGR of 7.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Cancer Biologics are monoclonal antibodies or proteins derived from living cells used to treat cancer. They work by precisely targeting specific cancer cells ... Read more

Cancer biologics include monoclonal antibodies, therapeutic vaccines and gene therapy, which help enhance the body's immune response against cancer. These biologics are widely used for the targeted treatment of various cancers such as breast cancer, lung cancer, prostate cancer and blood cancer. Targeted biologics interfere minimally with the normal functioning of the body's cells and are considered superior to conventional chemotherapies in terms of safety and effectiveness. The growing ... Read more